Pathophysiology Nodes

4
4 shared nodes are defined in this module.

Cell Types

0
No cell types are annotated for this module.

Biological Processes

4
Telomere Maintenance via Telomere Lengthening GO:0010833 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased Telomere Maintenance via Telomere Lengthening (GO:0010833). GO:0010833 is a biological process from the Gene Ontology. DECREASED Replicative Senescence GO:0090399 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Replicative Senescence (GO:0090399). GO:0090399 is a biological process from the Gene Ontology. INCREASED Telomere Maintenance via Telomerase GO:0007004 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Telomere Maintenance via Telomerase (GO:0007004). GO:0007004 is a biological process from the Gene Ontology. INCREASED Cell Population Proliferation GO:0008283 Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Cell Population Proliferation (GO:0008283). GO:0008283 is a biological process from the Gene Ontology. INCREASED
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "enabling_replicative_immortality#Telomere Maintenance Reactivation"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding biological processes and causal edges, specialized to their tumor context. Key tumor-specific substitutions: melanoma and glioblastoma use TERT promoter mutations; pediatric/ATRX-DAXX-mutant tumors use ALT. The opposing tumor-suppressive reading of telomere attrition / senescence as a barrier is captured in cellular_senescence and senescence_tumor_suppression. Key conformance target: "enabling_replicative_immortality#Telomere Maintenance Reactivation".

Used By Disorder Entries

9

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Enabling Replicative Immortality Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.

Pathophysiology

4
Progressive Telomere Attrition
trigger
Because conventional DNA polymerases cannot fully replicate chromosome ends (the end-replication problem), telomeres shorten with each cell division in cells lacking active telomerase. As a premalignant clone expands, telomeres erode toward a critically short length, which normally signals a DNA-damage response and engages the replicative-senescence or crisis barrier.
Telomere Maintenance via Telomere Lengthening GO:0010833 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Telomere Maintenance via Telomere Lengthening (GO:0010833). GO:0010833 is a biological process from the Gene Ontology. DECREASED
Replicative Senescence and Crisis Barrier
effector
Critically short, uncapped telomeres are recognized as DNA double-strand breaks, activating p53/RB-dependent replicative senescence (the Hayflick limit) or, if those checkpoints are bypassed, a crisis state marked by chromosome end-to-end fusions and massive cell death. This barrier limits the number of divisions a lineage can complete and must be overcome for a clone to become immortal.
Replicative Senescence GO:0090399 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Replicative Senescence (GO:0090399). GO:0090399 is a biological process from the Gene Ontology. INCREASED
Telomere Maintenance Reactivation
central effector
A rare clone reactivates a telomere-maintenance mechanism, stabilizing telomere length and escaping the senescence/crisis barrier. In the great majority of human cancers this occurs through reactivation of telomerase (TERT) - via TERT promoter mutations, amplification, or rearrangement - while a minority use the recombination-based alternative lengthening of telomeres (ALT) pathway, frequently associated with ATRX/DAXX loss. This is the conserved central node disorder-specific lesions converge upon.
Telomere Maintenance via Telomerase GO:0007004 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Telomere Maintenance via Telomerase (GO:0007004). GO:0007004 is a biological process from the Gene Ontology. INCREASED
Replicative Immortality
consequence
With telomeres stabilized, the cancer cell lineage acquires unlimited proliferative capacity - replicative immortality - decoupling division number from the telomere clock. This sustains the extensive clonal expansion required for macroscopic tumor growth and progression.
Cell Population Proliferation GO:0008283 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Cell Population Proliferation (GO:0008283). GO:0008283 is a biological process from the Gene Ontology. INCREASED